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Abstract
Recent outbreaks of human enterovirus 71 (EV71) infection and EV71-associated hand, foot, and mouth disease (HFMD) in
China have affected millions and potentially lead to life-threatening complications in newborns. Furthermore, these
outbreaks represent a significant global public health issue in the world. Understanding the epidemiology of HFMD and
EV71 infection and their transmission patterns in China is essential for controlling outbreaks. However, no studies on the
outbreaks of HFMD and EV71 infection in China during 2010 have been reported. In this report, we carried out an
epidemiological analysis to study an outbreak of HFMD and EV71 infection in 2010 in the city of Nanchang in the Jiangxi
province of People’s Republic of China. From April 7 to May 11, 2010, a total of 109 HFMD cases were reported, and in this
report the HFMD cases were studied by both epidemiological and laboratory analyses. The epidemiological study indicates
that children aged younger than 8 years old represented more than 90% of the reported cases, with the age group of 1–3
years containing the highest number of cases. Laboratory studies detected a high prevalence of EV71 amongst the cases in
our study, suggesting EV71 as a common enterovirus found in HFMD cases in Nanchang. Phylogenetic analysis of the
sequence of the VP1 region of four EV71 isolates indicated that the Nanchang strains belong to the C4 subgenotype
commonly found in China during outbreaks in 2008 but contain distinct variations from these strains. Our study for the first
time characterizes the epidemiology of HFMD and EV71 infection in China in 2010 and furthermore, provides the first direct
evidence of the genotype of EV71 circulating in Nanchang, China. Our study should facilitate the development of public
health measures for the control and prevention of HFMD and EV71 infection in at-risk individuals in China.
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Introduction
Hand, foot, and mouth disease (HFMD), a common illness in
children aged ,10 years, is generally a benign febrile exanthem-
atous disease but may cause potential life-threatening neurological
and systemic manifestations such as encephalitis [1]. Human
enterovirus 71 (EV71) and coxsackievirus A16 (CA16) are the
most common causes of HFMD, although several other human
enteroviruses such as coxsackievirus A4–A7, B2–B5, and entero-
virus 18, can also cause the disease [2]. Clinical features of HFMD
caused by these viruses are indistinguishable. The infection
typically has an incubation period of 3–5 days. The main clinical
manifestations are the appearance of vesicles on the palmar and
plantar skin, buccal mucosa, and tongue, which may be associated
with fever and lymphadenopathy [1,2]. The oral enanthem helps
to distinguish HFMD from other causes of childhood exanthems,
although cases without lesions have been described [1,3].
Uncomplicated HFMD usually resolves in 5–6 days; however,
those caused by EV71 are more likely to be severe and carry
a higher risk of developing neurological and cardiopulmonary
complications and death [4,5]. The predominant forms of
neurological complications include aseptic meningitis and brain-
stem encephalitis. As a complication of systemic EV71 infection,
acute cardiopulmonary failure such as pulmonary oedema has a
high mortality rate [3,6]. Understanding the epidemiology of
human enteroviruses is central in controlling the infection of
human enteroviruses and preventing enterovirus-associated com-
plications including HFMD.
In the past three decades, the occurrence of HFMD cases,
especially those associated with EV71, has resulted in major
outbreaks throughout the world, including the US, Europe, Asia,
South America, and Africa [1,3]. The largest HFMD epidemic to
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people were infected with human enteroviruses, with over
129,000 cases of HFMD or herpangina and 405 severe cases
with complications including encephalitis, aseptic meningitis,
pulmonary edema, hemorrhage-related acute flaccid paralysis,
and myocarditis [7]. This epidemic eventually resulted in 78
deaths, most of which were due to EV71, and was followed by
more outbreaks in other parts of the Asia-Pacific region,
including Australia, Singapore, and Japan [8,9,10]. The latest
large epidemic occurred in China in 2008. More than 600,000
HFMD cases and 126 deaths in children were reported from
March 2008 to June 2009 [11]. At the epicenter in Anhui
Province, more than 6,000 HFMD cases and 22 deaths in
children were reported [11]. In addition to these large outbreaks,
many areas, including Australia, Japan, Singapore, Taiwan, and
Vietnam, have experienced cyclical epidemics that occur every 2–
3 years [8,9,10]. Because of their large size and high frequency,
EV71- and other enterovirus-associated HFMD epidemics have
become an important public health issue in the world, especially
in the Asia-Pacific region [1,3].
As a non-enveloped virus, enteroviruses are relatively stable in
the host environment as compared to enveloped viruses. The lack
of a lipid envelope confers their resistance to organic solvents (e.g.
ether and chloroform), alcohol, and freezing. Enteroviruses are
able to survive exposure to human gastric acid, and can survive at
room temperature in the environment for several days [2]. They
can be detected in surface and ground water and in hot spas
[12,13]. These properties are believed to facilitate the extremely
efficient transmission of human enteroviruses, even though
humans are the only known natural hosts for these viruses [2].
With a RNA genome whose replication is mediated by an error-
prone RNA-dependent RNA polymerase, enteroviruses mutate
and evolve rapidly, leading to the generation of new viral variants
[2]. Furthermore, as co-infection is common in infected individ-
uals, existing viral strains can undergo intra- and intertypic
recombination, leading to new viral variants [14,15,16,17,18]. The
emergence of novel viral variants and genotypes/subgenotypes are
believed to facilitate the transmission of these viruses to individuals
who do not have pre-existing immunity, significantly contributing
to the outbreaks of EV71 and HFMD [1,3].
Treatment of EV71 infection and HFMD is limited as there is
currently no effective chemoprophylaxis or vaccination for HFMD
or EV71 infection [1,3]. Public health-mediated strategies to block
viral transmission represent the best options for controlling and
preventing HFMD and EV71 infection. These strategies rely on
good personal hygiene practices and social distancing measures,
such as isolating the infected cases from schools and preventing
further transmission of the viruses [1,3]. The effectiveness of these
measures in controlling the spread of human enteroviruses remains
to be defined, and their contribution to the prevention of HFMD
outbreaks needs to be further studied, especially in developing
countries where sewage treatment, quality of portable water
supply, and food hygiene can be suboptimal. Understanding the
epidemiology of HFMD and enterovirus infection is essential for
developing relevant public health measures for controlling their
outbreaks.
Extensive studies have been carried out to examine the
epidemiology of HFMD and enterovirus infection during the
epidemic in Taiwan in 1998, as well as in outbreaks in other parts
of the world including Japan, Hong Kong, the United States, and
Europe [19,20,21,22,23,24,25,26,27,28]. The epidemics of en-
terovirus infection in China represent a significant public health
issue to the Asia-Pacific region, and potentially a global issue as a
result of the efficient transmission and rapid spread of the
constantly mutating and evolving viruses. Thus, it is important to
examine the epidemiology of HFMD and enteroviruses and
monitor their transmission patterns in China. However, little is
known about the epidemiology of HFMD and EV71 infections
during the epidemic in China since 2008 [11,29,30,31]. No studies
on the outbreaks of HFMD and enterovirus infection in China
during 2010 have been reported.
In this report, we studied an outbreak of HFMD and
enterovirus infection in the city of Nanchang from April 7 to
May 11, 2010. Nanchang is the capital city of Jiangxi Province,
the southwest province adjacent to Anhui province, which was
the epicenter of the 2008 HFMD epidemic (Figure 1). A total of
109 HFMD cases were reported and analyzed. Our epidemio-
logical analyses indicate that children aged younger than 8 years
old represented 90% of the reported cases, with the age group of
1–3 years containing the highest number of reported HFMD
cases. Laboratory studies detected a high prevalence of EV71
amongst the cases in our study, suggesting EV71 as a common
enterovirus found in HFMD cases in Nanchang. Phylogenetic
analysis of the nucleotide sequences from the VP1 region of four
EV71 isolates indicated that the Nanchang strains belong to the
C4 subgenotype commonly found in China in 2008 but contain
distinct variations from those strains. Our results reveal the
epidemiological features of HFMD and EV71 infection in China
in 2010 and provide insight into developing public health
interventions for the control and prevention of HFMD and
enterovirus in at risk individuals.
Figure 1. Geographic location of Nanchang in China (A) and of different HFMD cases (represented in red) in the metropolitan area (B) and city of
Nanchang (C).
doi:10.1371/journal.pone.0025287.g001
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Design of the study
During the period from April 7 to May 11, 2010, each patient
who exhibited clinical symptoms of HFMD and who came or were
referred to the outpatient clinic at the 9th People’s Hospital of
Nanchang was recorded. A case was defined as a patient who had
clinical symptoms of HFMD, typically vesicles on the hand or foot,
and oral lesions, with or without fever. For each patient, a
thorough medical exam was given to check on other HFMD-
associated symptoms, both throat swab and fecal samples were
collected, and a clinical questionnaire and survey was filled out. In
total, 109 cases were recorded. Based on these information and
samples, two different sets of analyses were carried out. First, we
carried out laboratory procedures, including conventional reverse
transcription-PCR (RT-PCR) and quantitative RT-PCR (qRT-
PCR), to analyze the samples for the presence of the sequences of
human enteroviruses, including EV71 and CA16, which are
among the most common causes of HFMD. Second, we
performed epidemiological analyses with the information from
the medical exams, completed questionnaires/surveys, and the
laboratory results on the detection of specific viruses.
Prevalence of human enteroviruses including EV71 and
CA16 in HFMD cases in Nanchang
Three sets of primers, which specifically amplify a ‘‘universal’’
sequence (EVU) commonly presented in all human enteroviruses,
and the specific sequences of EV71 and CA16, were used to detect
the presence of human enterovirus, EV71, and CA16, respectively.
Special considerations and precautions were taken to interpret the
PCR results and define the presence of viruses in the sample. First,
all samples were subjected to a multiplex qRT-PCR assay, which
simultaneously detects the presence of human enterovirus, EV71,
and CA16. Only those samples (e.g. NC10013) that were positive
in both the EVU and EV71 sequence and negative in the CA16
sequence were classified as EV71 positive, while only those
samples (e.g. NC10018) that were positive in both the EUV and
CA16 sequence and negative in the EV71 sequence were classified
as CA16 positive (Figure 2, Table S1). Second, all samples were
subjected to conventional RT-PCR with each of the three sets of
primers. The amplified PCR products corresponding to the
common EVU of human enteroviruses, and specific sequences of
EV71 and CA16 were separated on agarose gels and detected by
staining (Figure 2). Only those samples (e.g. NC10013) that were
positive for both the EVU and EV71 sequence and negative for
the CA16 sequence were classified as EV71 positive, while only
those (e.g. NC10018) positive for both the EVU and CA16
sequence and negative for the EV71 sequence were classified as
CA16 positive. Third, both conventional PCR and qRT-PCR
assays were carried out in duplicate for each sample and repeated
three times, and only those samples with two or more positive
results were considered to be positive. Fourth, only those samples
that were positive in both conventional RT-PCR and qRT-PCR
assays were defined to contain the respective virus. Samples with
co-infection of CA16 and EV71, which were CA16 and EV71
positive, were considered EVU-positive as these samples were
found to contain the EVU in our assays. Finally, to further confirm
the RT-PCR and qRT-PCR results, some of the samples that were
tested as positive for EV71 and CA16 were further cultured and
examined for the presence of infectious viruses. EV71 viruses were
isolated from the cultures, PCR products were cloned and the
presence of EV71 VP1 sequence in the PCR products was verified
by sequencing analysis of the cloned inserts.
Of the 109 HFMD cases, 70 (64.2%), 19 (17.4%), and 63
(57.8%) were found to contain the EVU, CA16, and EV71
sequences, respectively, suggesting that these patients were
infected with an enterovirus, CA16, and EV71, respectively
(Table S1). Furthermore, 12 (11.0%) were found to contain both
EV71 and CA16, suggesting that these patients were co-infected
with both EV71 and CA16. All the EVU-positive samples (70
cases) were also found to contain either the EV71 (63 cases or
90%) or CA16 sequence (19 cases or 27.1%) (Table S1). These
results indicate that all HFMD cases in Nanchang were either
infected with EV71 or CA16, and suggest that HFMD in
Nanchang is more likely to be associated with EV71 infection
than with CA16 infection.
Weekly distributions of HFMD cases and incidence of
viral infection
Between April 7 and May 11 of the year 2010, the 9
th People’s
Hospital of Nanchang recorded 109 suspected HFMD cases. The
Figure 2. PCR reactions detecting the VP1 sequence of
enterovirus 71 from samples isolated from different HFMD
cases in Nanchang. RT-PCR reactions were carried out in the absence
of any RNA samples (negative control)(N, lane 2) or in the presence of a
positive RNA sample (P, lane 3) or RNA samples isolated from HFMD
cases NC10013 (lane 4), NC10014 (lane 5), NC10015 (lane 6), NC10016
(lane 7), NC10017 (lane 8), NC10018 (lane 9), NC10019 (lane 10),
NC10020 (lane 11), and NC10021 (lane 12). The amplified products were
separated in 1% agarose gels. M, DL2000 DNA marker ladder (TaKaRa)
(lane 1).
doi:10.1371/journal.pone.0025287.g002
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The outbreak in Nanchang spanned a time period of approxi-
mately 5 weeks, peaking during the week of April 21 to April 27
(Figure 3). The start and end dates of the April-May outbreak are
consistent with the outbreaks in Hong Kong and Taiwan, where
HFMD outbreaks occurred during late spring to early summer
[3,8]. During the following months from June to October, less
than 20 HFMD cases were reported at the same hospital.
Amongst 109 HFMD cases, the majority (96.2%) of the cases
were in children 8 years or younger, with 4 cases that were older
than 30 years; the mean age being 4.37 years old. The peak of age
was 1 to 2 years old (Figure 4A). When excluding cases aged
greater than 8 years old, there is an overall decline of cases as the
age of the patients increases. This finding is consistent with
previous reports that the majority of HFMD cases are found in
children aged younger than 10 years [1,22,29]. Furthermore, the
age peak found in the HFMD outbreak of Nanchang shows that
HFMD occurred most often in children of 1 year old (Figure 4A).
This indicates that children of 1 year of age should in particular be
targeted for HFMD control and prevention.
Of the HFMD cases, 51 cases were younger than 3 years and 55
cases were older than 3 years. Most Chinese children remain at
home under the care of parents or relatives until 3 years of age and
start attending preschool after that. Our results showed that 48.1%
of HFMD cases were younger than 3 years old while 51.9% of
cases were three years old or older (Figure 4A), suggesting that the
occurrence of HFMD had little relation with schooling in
Nanchang. Thus, schooling may not play a significant role in
the transmission of HFMD in Nanchang.
Seventy specimens (64.2%) were determined as EVU positive, 63
specimens (57.8%) weredetermined as EV71 positive, 19 specimens
(17.4%) were determined as CA16 positive and 12 specimens
(11.0%) were determined as a co-infection of CA16 and EV71
(Table S1). The cases of EV71 infection appeared to be consistent
with the pattern of the HFMD outbreak; EV71-positive cases were
found to decrease as HFMD cases decreased in the age groups of 2
to 5 years old (Figure 4B). In contrast to EV71, CA16 infection does
not correlate as well with HFMD infection patterns. As is evident in
Figure 4B,the numberof CA16 cases increased from the agegroups
of 2 to 4. This notion is also further supported by the prevalence
(57.8% in all HFMD and 90% in all EV-positive cases, respectively)
of EV71 in the patients’ samples (Figure 4B). These observations
suggest EV71 as the most common enterovirus found in HFMD
cases and a possible cause of the HFMD outbreak in Nanchang.
Gender distribution of HFMD cases and infection of
viruses
When excluding 6 cases lacking gender information, amongst
the HFMD cases, 64.5% were boys (60 cases) and 35.5% were girls
Figure 3. Weekly distribution of the cases of HFMD (A) and those that were tested positive in our PCR assays for enterovirus (EVU), enterovirus 71
(EV71), and coxsackievirus 16 (CA16), and positive for both EV71 and CA16 (CA16/EV71), respectively (B).
doi:10.1371/journal.pone.0025287.g003
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32.1% (18) of the cases were girls (Figure 5). The number of male
EV71 cases is almost twice the number of female cases.
Symptom distribution amongst HFMD cases in Nanchang
Of the 109 cases of HFMD, only 4 cases had fever, 3 of which
were the only cases requiring hospitalization (Table 1). All febrile
cases were 2 years or younger. The majority of the HFMD cases in
Nanchang exhibited sores in the mouth and on the hands, with a
few cases of sore throat (2 cases) and loss of appetite (3 cases)
(Table 1).
Geographical distribution of HFMD cases in Nanchang
Of all 109 reported HFMD cases, 52 (47.7%) were found in the
Qingshanhu district, suggesting that the transmission patterns of
those cases were unique and different from other districts in
Nanchang (Table 2, Table 3). The majority of the cases in the
Qingshanhu district were caused by EV71 (Table 2, Table 3).
Further analysis of the geospatial distribution within the
Qingshanhu district revealed two HFMD case clusters: one in
the Nanchang Steel Mill Industrial Park and the other in the
Jiangxi Tire Manufacturing Industrial Park (Figure 1C). For
further investigation of these two clusters, field trips were made to
both areas. Both Industrial Parks contain manufacturing factories,
community complexes, shopping and business districts and
schools.
Molecular characterization of EV71 strains in Nanchang
To characterize the EV71 strains circulating in Nanchang and
investigate their genetic origin, we isolated viruses from four
Figure 4. Age distribution of the cases of HFMD (A) and those that were tested positive in our PCR assays for enterovirus (EVU), enterovirus 71
(EV71), and coxsackievirus 16 (CA16), and positive for both EV71 and CA16 (CA16/EV71), respectively (B).
doi:10.1371/journal.pone.0025287.g004
Figure 5. Gender distribution of the cases of HFMD and those
that were tested positive in our PCR assays for enterovirus
(EVU), enterovirus 71 (EV71), and coxsackievirus 16 (CA16),
and positive for both EV71 and CA16 (CA16/EV71), respec-
tively.
doi:10.1371/journal.pone.0025287.g005
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regions of Nanchang and patients from different age groups, by
culturing them in rhabdomyosarcoma (RD) cells. The isolation of
EV71 viruses from these samples further confirms our PCR
results. The isolated viruses will be used for further analysis of the
biological properties of the EV71 viruses circulating in Nanchang.
The VP1 regions of these four EV71 isolates were amplified by
PCR, cloned, and sequenced. Figure 6 shows the alignment of the
nucleotide sequence of the VP1 region of the four EV71 isolates
from Nanchang and the reference strains EV71-BrCr (a genotype
A strain that was isolated in California in 1968) and EV71-FYC4
(a genotype C4 strain that was isolated in Fuyang, Anhui of China
in 2008) obtained from GenBank, using the Clustal W program
[32]. Using the neighbor-joining algorithm in MEGA software, we
constructed a phylogenetic tree with the sequences of these four
isolates and 36 reference EV71 strains from Genbank [33]
(Figure 7). The reference viruses consisted of EV71 strains isolated
from different parts of the world during the last four decades, and
can be classified into three large groups corresponding to
genotypes A, B, and C. The phylogenetic analysis revealed that
the Nanchang isolates are grouped into the same cluster of
genotype C, and have a close evolutionary relationship with EV71
strains of the C4 subgenotype lineage. EV71 strains of the C4
subgenotype lineage have been commonly found in China during
the EV71 outbreaks in 2008 [11,29,31] and are distinct from those
virus strains circulating in Australia, Europe, and US. Indeed, all
four Nanchang sequences cluster well with the VP1 sequences of
the EV71 viruses recently found in China (within the C4
subgenotype lineage) but not those EV71 strains circulating in
the rest of the world such as Australia, Europe, and US (Figure 7).
This result indicates that these Nanchang EV71 strains belong to
the subgenotype C4 and may have originated from adjacent
provinces in China such as Anhui, the epicenter of EV71
outbreaks in 2008.
Discussion
In this study, we have carried out an epidemiological analysis to
study an outbreak of HFMD and human enterovirus infection in
Nanchang, China between April 7 and May 11, 2010. Our results
provide direct evidence that children aged 8 years old or younger
represented more than 90% of the reported cases, with the age
group of 1–3 years containing the highest number of HFMD and
EV71-positive cases. Seventy samples were positive for human
enteroviruses, 63 which contained EV71 and 19 of which
contained CA16. Our study represents the first to investigate the
epidemiology of HFMD and EV71 infection during outbreaks in
China in 2010.
It is possible that the epidemiological analysis carried out in this
study may not truly represent the transmission and distribution of
HFMD and viral infections during outbreaks as data collection
may have been artificial and partial, and the laboratory analyses
Table 1. Clinical and laboratory characteristics of different aged groups of HFMD cases in Nanchang.
Age Under 1 1 2 3 4 5 678O v e r 1 8
Case (No. and %) 8(7.3) 24(22.0) 20(18.3) 17(15.6) 15(13.8) 10(9.2) 5(4.6) 5(4.6) 1(0.9) 4(3.7)
EV71 (No. and %) 3(37.5) 17(70.8) 11(55.0) 11(64.7) 10(66.7) 8(80.0) 1(20.0) 1(20.0) 0(0.0) 1(25.0)
CA16 (No. and %) 1(12.5) 4(16.7) 3(15.0) 5(29.4) 5(33.3) 0(0.0) 0(0.0) 1(20.0) 0(0.0) 0(0.0)
Both EV71 and CA16 (No. and %) 0(0.0) 3(12.5) 1(5.0) 3(17.6) 4(26.7) 0(0.0) 0(0.0) 1(20.0) 0(0.0) 0(0.0)
Negative for EV71 or CA16 (No. and %) 4(50.0) 6(25.0) 7(35.0) 4(23.5) 4(26.7) 2(20.0) 4(80.0) 4(80.0) 1(100.0) 3(75.0)
Fever (No. and %) 0(0.0) 3(12.5 ) 1(5.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Sore throat (No. and %) 0(0.0) 2(8.3) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Loss of appetite (No. and %) 0(0.0) 2(8.3) 1(5.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Oral lesion (No. and %) 8(100.0) 24(100.0) 20(100.0) 17(100.0) 15(100.0) 9(90.0) 5(100.0) 5(100.0) 1(100.0) 4(100.0)
Vesicles on hand and foot (No. and %) 8(100.0) 24(100.0) 20(100.0) 16(94.1) 15(100.0) 9(90.0) 5(100.0) 5(100.0) 1(100.0) 4(100.0)
doi:10.1371/journal.pone.0025287.t001
Table 2. Distribution of the numbers of HFMD cases in
different districts of Nanchang.
District HFMD Cases
Donghu 5
Fuzhou 1
Gan 1
Honggutan 3
Nanchang 8
Qingshanhu 52
Qingyunpu 5
Xihu 17
Xinjian 9
doi:10.1371/journal.pone.0025287.t002
Table 3. Distribution of the incidences of viral infections in
different districts of Nanchang.
District EVU EV71 CA16 CA16/EV71
Donghu 2 1 1 0
Fuzhou 0 0 0 0
G a n 0 000
Honggutu 3 3 0 0
Nanchang 2 2 1 1
Qingshanhu 38 33 14 9
Qingyunpu 5 5 2 2
Xihu 9 9 0 0
Xinjian 6 5 1 0
doi:10.1371/journal.pone.0025287.t003
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generated in the RT-PCR and qRT-PCR assays. To address
these issues, we have carefully designed the study and have taken
special precautions to interpret the results. First, all clinical data
were obtained in the 9
th People’s Hospital of Nanchang, which is
the only regional hospital in the city specializing in infectious
diseases. As such, most of the patients that were suspected of
HFMD and seen in other hospitals in the city, such as the
Children’s Hospital of Nanchang, were referred to the 9
th
Hospital. Second, each patient was given a thorough medical
exam, throat swab and fecal samples were collected, and a clinical
questionnaire and survey was filled out. Third, to prevent false
positive and negative results in the laboratory tests, each sample
was subjected to both conventional PCR and qRT-PCR assays.
For each assay, three sets of primers amplifying a common
‘‘universal’’ sequence of enterovirus and specific sequences of
EV71 and CA16 were used to specifically detect the presence of
human enterovirus, EV71, and CA16, respectively. Each assay
was performed in duplicate and repeated three times, and only
those samples that were tested positive consistently in both assays
were defined as positive for the viruses. Finally, to further confirm
the RT-PCR and qRT-PCR results, some of the samples that were
tested positive for EV71 and CA16 were further cultured and
examined for the presence of infectious viruses. Thus, we believe
that the results presented in this study may accurately represent
the epidemiology of HFMD and enteroviruses in the patient
population in Nanchang in 2010.
To characterize the EV71 strains circulating in Nanchang, we
isolated viruses from the four EV71-positive samples that were
used for sequencing analysis of the VP1 region, by culturing them
in rhabdomyosarcoma (RD) cells. These four samples were from
patients representing different geographic regions of Nanchang
and from different age groups. The isolation of EV71 viruses from
these samples further confirms our PCR results, and will be used
for further analysis of the biological properties of the EV71 viruses
circulating in Nanchang. We note that all our HFMD cases did
not exhibit severe neurological and cardiopulmonary complica-
tions. Further investigation of the HFMD cases in China,
including the isolation and characterization of the viruses from
those cases exhibiting neurological and cardiopulmonary compli-
cations, will help reveal the correlation between EV71 infection
and severe HFMD-associated complications.
It is generally believed that enteroviruses transmit among
individuals via intra-familial and intra-community routes including
attendance in schools [34,35]. Previous studies have indicated that
intra-familial transmission occurs commonly [35]. In a prospective
cohort, the rate of symptomatic infection after household
transmission is higher than that in other community settings,
possibly because of more prolonged contact with the cases and a
larger infective dose [35]. Furthermore, transmission rates from
infected children to siblings were as high as 84% [35]. Our results
are consistent with these observations. Most of the children 1 year
old or younger did not attend any day care schools and were
instead cared for at home by family members, primarily parents
and relatives in our study based on our telephone interview survey.
Most of these children never had contact with people outside of
their immediate household members, strongly suggesting that they
contracted the disease and enterovirus from family members. Due
to the current one child per family policy in China, it is difficult to
assess the transmission from infected children to siblings within a
household. Our results suggest that asymptomatic adult carriers of
human enteroviruses such as EV71 and CA16 may represent a
major reservoir for the transmission of these viruses in a household
setting, although we can not rule out other possible unidentified
means of transmission within the households of these affected
children. Little is currently known about the level of viral shedding
from these adult carriers. Our results suggest that screening of
asymptomatic adult carriers may be necessary in order to prevent
the transmission of HFMD and EV71 to children 1 year old or
younger, who may be most at-risk to infection.
Our preliminary genotype analysis primarily focused on the
viruses isolated from the EV71-positive samples. EV71 has been
Figure 6. Nucleotide sequence comparison of a part of the VP1 genes between four EV71 strains isolated in Nanchang and the
reference viruses EV71-BrCr (BrCr) and EV71-FYC4 (FYC4). The nucleotides that are not identical among all the virus sequences are
highlighted. Numbering starts at the 59 terminus of the EV71 genome.
doi:10.1371/journal.pone.0025287.g006
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CA16 and several EV71 subtypes associated with different clinical
manifestations have been reported, while CA16 appears to be
more homogenous and have fewer subtypes than EV71 and is
much less associated with severe HFMD-associated complications
than EV71 [1,2]. It will be interesting to determine the genotype of
the CA16 virus isolates from our HFMD samples. Meanwhile, it is
difficult to determine the statistical difference among the study
groups in the current study, possibly due to the small size of the
samples and the complexity of the issues between HFMD and
EV71/CA16 infections. It will be important to carry out detailed
statistical analyses on a larger sample size and these analyses will
further elucidate the correlation between EV71/CA16 infections
and HFMD-associated diseases.
Figure 7. Phylogenetic analysis of the four EV71 isolates from Nanchang and the reference viruses. The evolutionary relationships
among these viruses were estimated by the method of the neighbor-joining method with 1000 bootstraps. Sequence comparisons to the reference
viruses were performed by a multiple alignment of the nucleotide sequences of the VP1 region.
doi:10.1371/journal.pone.0025287.g007
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Anhui Province of China in 2008, most of our cases are benign
and none of our cases was severe or associated with neurological
complications. This is surprising since a substantial number of
cases were infected by EV71, which usually induces a much more
severe illness than coxsackievirus A. One possibility is the unique
susceptibility of individuals in Nanchang to enterovirus strains. It is
also possible that the viral strains in Nanchang are attenuated
and different from those circulating in other epidemic regions
including the Anhui Province. No cases of HFMD or EV71
infection in the Nanchang area have been previously reported.
Our results in this study provide the first direct evidence that four
EV71 strains isolated from the HFMD cases in Nanchang are
genotype C4 viruses. Phylogenetic analyses suggest that these
isolates may be closely related to those circulating in adjacent
Chinese provinces such as Anhui Province but contain distinct
mutations at the VP1 region which sequences have been
determined. It is currently unknown whether these mutations
may contribute to the attenuated complications associated with the
patients infected with these isolates. It is also unclear whether these
isolates also contain mutations at other regions of the viral
genome. Determination of the genomic sequence of these strains
and characterization on their ability to replicate and cause
pathogenesis will clarify these important issues. Further studies on
these important issues will facilitate the control and prevention of
the infections of human enteroviruses and their associated diseases
including HFMD.
Materials and Methods
Ethics Statement
All research involving human participants was approved by the
Institutional Review Board of the College of Life Sciences, Wuhan
University (Wuhan, China), leaded by Dr. Hongbing Shu, the Dean
of the college,inaccordancewith the guidelinesfortheprotection of
human subjects. Written informed consent was obtained from each
participant. No research involving human participants was carried
out at the University of California-Berkeley.
Clinical information and specimen collection
All reported HFMD cases in Nanchang were recorded by
medical practitioners of the 9
th People’s Hospital of Nanchang. All
cases were used in this study. Cases consisted of children and
adults living within the districts of Nanchang, Jiangxi province.
HFMD patients were diagnosed mainly by observation of the
presence of hand or mouth blisters. In many cases, the parents of
the patients noticed the sores and, out of worry, sent their children
to the hospital to check for HFMD. Documentation of patients’
name, age, symptoms and contact information was performed by
doctors of the 9
th People’s Hospital of Nanchang. Hospital
scientists then used the documents to organize and fill the
mentioned information into clinical surveys conducted by the
hospital. These surveys were collected from the hospital and used
in this research project for an epidemiologic study. Throat swabs
and fecal samples were also collected from each case when
applicable by medical practitioners of the 9
th People’s Hospital of
Nanchang. These samples were used in the lab for viral isolation
and diagnosis. Several cases had visited the smaller hospitals
within their district area before being referred to the 9
th People’s
Hospital of Nanchang.
Telephone interviews and site visits
Telephone interviews were carried out in order to obtain
additional information about patients’ activities during and prior
to their infected period. Telephone numbers were used from the
contact information collected from the clinical surveys. Parents of
the patients were contacted and questioned regarding the activities
of their child and other details. Responses were then collected and
stored in a survey. In addition, two trips were made, in the August
and December of 2010, to Nanchang by car to the 9
th People’s
Hospital of Nanchang and preschools and Chengdong primary
school in the industrial park areas where there occurred clusters of
HFMD cases. Playgrounds and classrooms were observed in all of
the schools. Sleeping areas were also observed in the preschools.
Teachers were interviewed regarding childrens’ activities during
school, the school’s prevention methods towards HFMD and
information known about the cases that occurred there. In
addition, the scientists responsible for creating and filling in the
clinical surveys were interviewed at the 9
th People’s Hospital of
Nanchang.
Viral RNA extraction from specimens and reverse
transcription
Viral RNA was extracted from the throat and fecal samples
received from the 9
th People’s Hospital of Nanchang using a
Roche High Pure Viral RNA Extraction Kit (Roche, Germany),
according to the manufacturer’s experimental protocols. Reverse
transcription was carried out in the presence of M-MLV Reverse
Transcriptase (Promega, USA), following the procedure provided
by Promega, Inc. Briefly, the following components were added to
a sterile RNase-free microcentrifuge tube in a reaction volume of
50 ml that contained 50 mM Tris-HCl (pH 8.3), 75 mM KCl,
3 mM MgCl2, 10 mM DTT, 200 unit M-MLV RT enzyme
(Promega, Inc.), 25 unit RNAsin (Promega, Inc.), 0.1 mM dATP,
0.1 mM dCTP, 0.1 mM dGTP, 0.1 mM dTTP, and the template
RNA samples. The reaction components were mixed gently and
incubated for 60 minutes at 37uC.
Conventional PCR analysis
Both conventional PCR and quantitative real-time PCR were
performed in this study to detect the presence of the common
(universal) sequence of enterovirus (EVU), and the specific
sequences of enterovirus 71 (EV71) and coxsackievirus 16
(CA16). Samples with co-infection of CA16 and EV71, which
were CA16 and EV71 positive, were considered as EVU-positive
as these samples were positive for the presence of EVU in our
assays. The conventional PCR mix (in a reaction volume of 25 ml)
contained the following: 10 mM Tris-HCl, pH 8.8, 50 mM KCl,
0.08% (v/v) Nonidet P40, 1.5 mM MgCl2,5 0mM dATP, 50 mM
dCTP, 50 mM dGTP, 50 mM dTTP, 0.4 mM forward primer,
0.4 mM reverse primer, 1 U Taq DNA polymerase (Fermentas,
Shenzhen, China), and the cDNA template samples. Each sample
was tested individually for the presence of the common (universal)
EV sequence (EVU), and the specific sequences of EV71 and
CA16. The forward and reverse primers for detection of the
universal EV sequence (EVU) is PE2 (59-tccggcccctgaatgcggc-
taatcc-39) and PE1 (59-acacggacacccaatagtcggtcc-39), respectively.
The forward and reverse primers for detection of the specific
EV71 sequence (EV71) is EV71-s (59-gcagcccaaaagaatcac-39) and
EV71-a (59-atttcagcagcttggagtgc-39), respectively. The forward
and reverse primers for detection of the specific CA16 sequence
(CA16) is CA16-s (59-attggtgctcccactacagc-39) and CA16-a (59-
tcagtgttggcagctgtagg-39), respectively. The conventional PCR
reactions were performed in a Veriti 96 Well thermal Cycler PCR
Instrument (Applied Biosystems, USA) under the following
conditions: 95uC for 3 min and 33 cycles of 95uC for 30 seconds,
50uC for 30 seconds, and 72uC for 40 seconds, followed by a final
72uC for 7 min. The amplified PCR products of the universal EV
Epidemiology of HFMD and EV71 Infection in China
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were separated on 1.5% agarose gels and stained with Gelred and
methyl blue.
Quantitative RT-PCR analysis
One-step real-time RT-PCR assays using FAM and VIC were
conducted to detect the presence of the universal EV (EVU)
sequence, and the specific EV71 and CA16 sequences in each
clinical sample. Samples with co-infection of CA16 and EV71,
which were CA16 and EV71 positive, were considered EVU-
positive as these samples were found to contain the EVU in our
assays. Reactions were prepared in a 25-mL volume by using a
One Step PrimeScript RT-PCR kit (BioPerfctus Technologies,
Inc., Shanghai, China) and performed in a Light Cycler 480 II
(Roche, Germany) using two different wavelength channels: FAM
and VIC. FAM detects the presence of EVU and CA16 while VIC
detects the presence of EV71, according to the protocols from
BioPerfctus Technologies, Inc. (Shanghai, China). For each
sample, one reaction was set up to detect EV71 and CA16 while
another reaction was set up to detect the EVU sequence. All the
reactions were performed in duplicate.
Sequencing and phylogenetic analyses
The amplified products from the conventional PCR reactions
were cloned into the pMD-18T vector (TaKaRA), and subse-
quently subjected to bi-directional DNA sequencing in Invitrogen,
Inc. (Shanghai, China). The Genbank accession numbers of the
VP1 sequences of the four EV71 isolates reported in this study are
JF892540-892543. Nucleotide BLASTn analysis (http://www.
ncbi.nlm.nih.gov/BLAST) was used to identify related reference
viruses, and the reference sequences were obtained from
GenBank. Pair-wise sequence alignments were performed with
the Megalign program (DNASTAR) to determine nucleotide and
amino acid sequence similarities. Those newly identified nucleo-
tide sequences were aligned with EV71 VP1 reference sequences
and sequences previously found in China, using Clustal W
program implemented with MEGA 4.0 [32,33]. To understand
the evolutionary characterization of EV71 viruses isolated in this
study, phylogenetic analyses of the aligned sequences for a part of
the VP1 gene were performed by the neighbor-joining method
with 1000 bootstraps using MEGA 4.0.
Data analysis
Information contained in the clinical surveys collected from the
9
th People’s Hospital of Nanchang were stored and filled into new
surveys using the data analysis program Epi Info (http://wwwn.
cdc.gov/epiinfo/). Data analysis was performed by calculating the
frequencies of the different variables within the surveys. For
certain variables some cases were omitted due to missing
information included on the corresponding surveys.
Supporting Information
Table S1 Detection of the presence of a human entero-
virus, EV71, and CA16 in the HFMD samples by quan-
titative real-time RT-PCR.
(DOC)
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